SCHEDULE 13G/A

CG oncology Inc

Common stock, $0.0001 par value per share · CUSIP: 156944100

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Decheng Capital Global Life Sciences Fund IV, L.P.

  Shares: 5,315,954.00 · Class: 7.0%

• Decheng Capital Management IV (Cayman), LLC

  Shares: 5,315,954.00 · Class: 7.0%

• Decheng Capital Global Healthcare Fund (Master), LP

  Shares: 1,055,715.00 · Class: 1.4%

• Decheng Capital Global Healthcare GP, LLC

  Shares: 1,055,715.00 · Class: 1.4%

• Xiangmin Cui

  Shares: 6,371,669.00 · Class: 8.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.